The EU and Japan are expanding the mutual recognition agreement they signed in 2004 to broaden the range of medicines for which they will recognize each other's manufacturing inspections. The agreement will now extend to sterile drugs, certain biologics including vaccines and immunologicals, and the active pharmaceutical ingredients of any medicine covered in the agreement.